相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G. Gebhart et al.
ANNALS OF ONCOLOGY (2016)
ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer
Haiyan Sun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Kristoff Muylle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Tumor Immunotargeting Using Innovative Radionuclides
Francoise Kraeber-Bodere et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
Laetitia E. Lamberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
Martha W. den Hollander et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Tumorigenesis: it takes a village
Doris P. Tabassum et al.
NATURE REVIEWS CANCER (2015)
Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J. van Asselt et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer
Idris Bahce et al.
EJNMMI RESEARCH (2014)
Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial
Chaitanya R. Divgi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
Kenji Tamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Immuno-PET of Cancer: A Revival of Antibody Imaging
Otto C. Boerman et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
Richard P. Baum et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (I-124-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R. Divgi et al.
LANCET ONCOLOGY (2007)
分享论文
